This year, drug companies have been living under a cloud of uncertainty created by the Trump administration. Threats of tough ...

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small ...

Cipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and Danish firm Novo Nordisk.

Thousands of people who used a weight-loss supplement will be receiving a portion of more than $400,000, according to the ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Cutting a single amino acid from the diet caused rapid, drastic weight loss in mice by converting white fat into ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

Ozempic is known take pounds off your body, but a noticeable side effect in the private area is proving otherwise for male users.

In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...